After suspending Covaxin clinical trials, Brazil closes EUA request

Credit: IndiaTimes- Published on July 27, 2021
After suspending the clinical trials of Covaxin following the termination of Bharat Biotech's MoU with its Brazilian partner Precisa Medicamentos, Brazil’s health regulator Anvisa (Agencia Nacional de Vigilancia Sanitaria) has now closed the emergency use authorisation (EUA) request for the Indian vaccine as well.​

You are here


💡 newsR Knowledge: Other News Mentions


Covaxin

Vaccine against COVID-19
SAGE members and Bharat Biotech officials will hold a meeting where safety and efficacy of Covaxin will be discussed on the basis trial data in India.
Credit: DNA - Published 2 days ago

India's indigenously-developed Covid vaccine Covaxin may soon receive Emergency Use Listing by the World Health Organisation, eventually enabling its recipients..
Credit: DNA - Published 4 days ago

Credit: IndiaTimes - Published 6 days ago

A person must take two doses of the anti-Covid vaccine, Covaxin, even after recovering from Covid-19, for being considered as a fully vaccinated individual, a..
Credit: IndiaTimes - Published 1 week ago


Brazil

Country in South America
Brazilian legend Pele is "recovering well" from a recent operation, his daughter says. after media reports he had been readmitted to intensive care.
Credit: BBC Sport - Published 2 days ago

The daughter of Brazil football legend Pele has said her father is "recovering well" after he was readmitted to hospital - just days after leaving intensive..
2 days ago • Sky News
Brazilian legend Pele says he feels ready for "90 minutes plus extra time" after leaving intensive care.
Credit: BBC Sport - Published 5 days ago

Brazilian football legend Pele to be moved out of intensive care as he continues his recovery from surgery for a colon tumour.
Credit: BBC Sport - Published 6 days ago


Bharat Biotech

Indian biotechnology company and vaccine manufacturer

Related news from verified sources

After suspending the clinical trials of Covaxin following the termination of Bharat Biotech's MoU with its Brazilian partner Precisa Medicamentos, Brazil’s...
on July 27, 2021 • IndiaTimes

After closing the emergency use authorisation (EUA) and Phase-3 clinical trials requests for Bharat Biotech’s Covaxin, Brazil’s health regulator Anvisa...
on July 28, 2021 • IndiaTimes

After closing the emergency use authorisation (EUA) and Phase-3 clinical trials requests for Bharat Biotech’s Covaxin, Brazil’s health regulator Anvisa...
on July 29, 2021 • IndiaTimes

You might like